Hematopoietic stem cells mobilized by granulocyte colony‐stimulating factor partly contribute to liver graft regeneration after partial orthotopic liver transplantation

On the basis of the recently recognized potential of hematopoietic stem cells (HSCs) to give rise to hepatocytes, we investigated whether HSCs mobilized by granulocyte colony‐stimulating factor (G‐CSF) or G‐CSF per se could contribute to faster recovery and promote tissue reparation after rats' (cross‐sex) partial orthotopic liver transplantation (PLTx). Sex‐mismatched (female to male) syngeneic rat PLTx was established. The recipients were repeatedly administrated recombinant G‐CSF for 5 consecutive days before (G‐CSF + PLTx group) and after PLTx (PLTx + G‐CSF group). Compared with those in PLTx group, CD34+ cells in peripheral blood and portal tract region increased from day 1 to 7 after transplantation in G‐CSF + PLTx group and from day 3 to 14 after transplantation in PLTx + G‐CSF group, respectively, which suggested that CD34+ HSCs were mobilized and migrated into liver graft. Compared with that in G‐CSF + PLTx and PLTx groups, there was a higher survival rate in the PLTx + G‐CSF group. On day 3 after surgery, the level of aspartate aminotransferase and alanine aminotransferase were lower, whereas the mitosis index, proliferating cell nuclear antigen–positive nuclei, bromodeoxyuridine (BrdU) incorporation, and graft‐to‐recipient weight ratio were higher in the PLTx + G‐CSF group. In contrast, these parameters had no significant difference between G‐CSF + PLTx and PLTx groups. To define the origin of proliferating cells reconstituting liver after injury, sry+ (sex‐determining region for Y chromosome) and sry+/cytokeratin 19+ (CK19) cells were quantitated. Higher percentage of sry+ and sry+/CK19+ cells in PLTx + G‐CSF was detected than in G‐CSF + PLTx groups on day 14 after surgery, although the liver engraftment rate still remained rather low. Some of the sry+/CK19+ cells in the portal tract areas were similar to hepatic oval cells/cholangiocytes. In conclusion, G‐CSF administration after PLTx greatly improved survival rate and liver regeneration of partial graft, partly by its mobilizing HSCs into the injured liver to differentiate into hepatocytes through hepatic oval cells'/cholangiocytes' engraftment. Liver Transpl 12:1129–1137, 2006. © 2006 AASLD.

[1]  S. Thorgeirsson,et al.  Hematopoietic cells as hepatocyte stem cells: A critical review of the evidence , 2006, Hepatology.

[2]  O. Dirsch,et al.  Impact of donor gender on male rat recipients of small‐for‐size liver grafts , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  John S. Van Arnam,et al.  Lack of a Fusion Requirement for Development of Bone Marrow-Derived Epithelia , 2004, Science.

[4]  S. Baylin,et al.  Hematopoietic stem cells convert into liver cells within days without fusion , 2004, Nature Cell Biology.

[5]  K. Matsuo,et al.  Elevation of serum hepatocyte growth factor during granulocyte colony‐stimulating factor‐induced peripheral blood stem cell mobilization , 2004, British journal of haematology.

[6]  I. Verma,et al.  Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Margeli,et al.  Granulocyte-Colony Stimulating Factor Administration Ameliorates Liver Regeneration in Animal Model of Fulminant Hepatic Failure and Encephalopathy , 2003, Digestive Diseases and Sciences.

[8]  George McNamara,et al.  Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. , 2003, Blood.

[9]  G. Vassilopoulos,et al.  Transplanted bone marrow regenerates liver by cell fusion , 2003, Nature.

[10]  M. Grompe,et al.  Cell fusion is the principal source of bone-marrow-derived hepatocytes , 2003, Nature.

[11]  S. Kitamura,et al.  G-CSF Promoted Bone Marrow Cells to Migrate into Infarcted Heart and Differentiate into Cardiomyocytes , 2003 .

[12]  I. Petit,et al.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. , 2002, Experimental hematology.

[13]  Irving L. Weissman,et al.  Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to Chemokines , 2002, The Journal of experimental medicine.

[14]  A. Ruifrok,et al.  Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. , 2002, The New England journal of medicine.

[15]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[17]  I. Weissman,et al.  Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. , 2001, Blood.

[18]  S. Mckercher,et al.  Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. , 2000, Science.

[19]  H. Blau,et al.  From marrow to brain: expression of neuronal phenotypes in adult mice. , 2000, Science.

[20]  Xin Wang,et al.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo , 2000, Nature Medicine.

[21]  Rebekah Gardner,et al.  Liver from bone marrow in humans , 2000, Hepatology.

[22]  Sunil Badve,et al.  Derivation of hepatocytes from bone marrow cells in mice after radiation‐induced myeloablation , 2000, Hepatology.

[23]  S. Fan,et al.  Minimum graft size for successful living donor liver transplantation. , 1999, Transplantation.

[24]  A. Margeli,et al.  Effect of Granulocyte Colony-Stimulating-Factor Administration on Tissue Regeneration Due to Thioacetamide-Induced Liver Injury in Rats , 1999, Digestive Diseases and Sciences.

[25]  W. Mars,et al.  Bone marrow as a potential source of hepatic oval cells. , 1999, Science.

[26]  T Kiuchi,et al.  Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. , 1999, Transplantation.

[27]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[28]  G. Minuk,et al.  Liver regeneration: methods for monitoring and their applications. , 1997, Journal of hepatology.

[29]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[30]  G. Klintmalm,et al.  Influence of donor and recipient gender on the outcome of liver transplantation. , 1996, Transplantation proceedings.

[31]  J. Emond,et al.  Fifty-percent partial liver transplantation in the rat. , 1996, Transplantation.

[32]  T. Starzl,et al.  Effect of donor age and sex on the outcome of liver transplantation , 1995, Hepatology.

[33]  M. Ratajczak,et al.  Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. , 2004, Blood cells, molecules & diseases.

[34]  M. Hussain,et al.  In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. , 2003, The Journal of clinical investigation.

[35]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[36]  R. Calne,et al.  A surgical experience with five hundred thirty liver transplants in the rat. , 1983, Surgery.

[37]  H. Harris,et al.  The Rat , 1958, Nature.